EDGAR Filing Documents for 0001171843-19-004706

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001171843-19-004706

Filing Date

2019-07-23

Accepted

2019-07-23 08:31:14

Documents

Period of Report

2019-07-23

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	f6k_072319.htm	6-K	13387
2	EXHIBIT 1.1	exh_11.htm	EX-1.1	250184
3	EXHIBIT 5.1	exh_51.htm	EX-5.1	10346
4	EXHIBIT 5.2	exh_52.htm	EX-5.2	8041
5	GRAPHIC	gkh.jpg	GRAPHIC	7864
6	GRAPHIC	gkh_footer.jpg	GRAPHIC	5645
	Complete submission text file	0001171843-19-004706.txt		301776

Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739

Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131

RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-35773 | Film No.: 19966830
SIC: 2834 Pharmaceutical Preparations